Back to state act
Description
On 10 October 2025, the United States announced a deal with AstraZeneca. Under the deal, the U.S. Department of Commerce will delay the implementation of Section 232 tariffs on pharmaceutical products...
Sign in to see full description
Intervention Details
Intervention Type
Local operations incentive
MAST Chapter
I: Trade-related investment measures
Implementation date
No implementation date
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 2 sectors
Affected Products
Sign in to access 13 products
Threads
See all
This intervention is not part of any Thread yet.